Publications

Publications 2010

Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol.
Schmidt-Lucke C, Fichtlscherer S, Aicher A, Tschöpe C, Schultheiss HP, Zeiher AM, Dimmeler S.
PloS one 2010; 5112010: e13790

Homing of progenitor cells to ischemic tissues.
Chavakis E, Dimmeler S.
Antioxidants & redox signaling 2011; 1542011Aug15: 967-80

Dietary restriction: standing up for sirtuins.
Baur JA, Chen D, Chini EN, Chua K, Cohen HY, de Cabo R, Deng C, Dimmeler S, Gius D, Guarente LP, Helfand SL, Imai S, Itoh H, Kadowaki T, Koya D, Leeuwenburgh C, McBurney M, Nabeshima Y, Neri C, Oberdoerffer P, Pestell RG, Rogina B, Sadoshima J, Sartorelli V, Serrano M, Sinclair DA, Steegborn C, Tatar M, Tissenbaum HA, Tong Q, Tsubota K, Vaquero A, Verdin E.
Science (New York, N.Y.) 2010; 32959952010Aug27: 1012-3; author reply 1013-4

Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice.
Orlandi A, Chavakis E, Seeger F, Tjwa M, Zeiher AM, Dimmeler S.
Basic research in cardiology 2010; 10562010Nov: 703-12

Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis.
Fadini GP, Maruyama S, Ozaki T, Taguchi A, Meigs J, Dimmeler S, Zeiher AM, de Kreutzenberg S, Avogaro A, Nickenig G, Schmidt-Lucke C, Werner N.
PloS one 2010; 572010: e11488

Circulating microRNAs: novel biomarkers for cardiovascular diseases?
Dimmeler S, Zeiher AM.
European heart journal 2010; 31222010Nov: 2705-7

Circulating microRNAs in patients with coronary artery disease.
Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S.
Circulation research 2010; 10752010Sep3: 677-84

Circulating microRNAs in patients with coronary artery disease.
Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S.
Circulation research 2010; 10752010Sep3: 677-84

Kruppel-like factor 2 improves neovascularization capacity of aged proangiogenic cells.
Boon RA, Urbich C, Fischer A, Fontijn RD, Seeger FH, Koyanagi M, Horrevoets AJ, Dimmeler S.
European heart journal 2011; 3232011Feb: 371-7

Regulation of bone marrow-derived vascular progenitor cell mobilization and maintenance.
Dimmeler S.
Arteriosclerosis, thrombosis, and vascular biology 2010; 3062010Jun: 1088-93

Comparative proteomics profiling reveals role of smooth muscle progenitors in extracellular matrix production.
Simper D, Mayr U, Urbich C, Zampetaki A, Prokopi M, Didangelos A, Saje A, Mueller M, Benbow U, Newby AC, Apweiler R, Rahman S, Dimmeler S, Xu Q, Mayr M.
Arteriosclerosis, thrombosis, and vascular biology 2010; 3072010Jul: 1325-32

Mechanism of improved cardiac function after bone marrow mononuclear cell therapy: role of cardiovascular lineage commitment.
Yoon CH, Koyanagi M, Iekushi K, Seeger F, Urbich C, Zeiher AM, Dimmeler S.
Circulation 2010; 121182010May11: 2001-11

Vascular microRNAs.
Bonauer A, Boon RA, Dimmeler S.
Current drug targets 2010; 1182010Aug: 943-9

Capture of endothelial progenitor cells by a bispecific protein/monoclonal antibody molecule induces reendothelialization of vascular lesions.
Langer HF, von der Ruhr JW, Daub K, Schoenberger T, Stellos K, May AE, Schnell H, Gauss A, Hafner R, Lang P, Schumm M, Bühring HJ, Klingel K, Conrad S, Schaller M, van Zandvoort M, Jung G, Dimmeler S, Skutella T, Gawaz M.
Journal of molecular medicine (Berlin, Germany) 2010; 8872010Jul: 687-99

Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy.
Assmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, Schächinger V, Seifried E, Zeiher AM, Dimmeler S.
Journal of the American College of Cardiology 2010; 55132010Mar30: 1385-94

Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells.
Doebele C, Bonauer A, Fischer A, Scholz A, Reiss Y, Urbich C, Hofmann WK, Zeiher AM, Dimmeler S.
Blood 2010; 115232010Jun10: 4944-50

Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia.
Minnerup J, Seeger FH, Kuhnert K, Diederich K, Schilling M, Dimmeler S, Schäbitz WR.
Experimental & translational stroke medicine 2010; 212010: 3

Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy.
Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S.
Atherosclerosis 2010; 21112010Jul: 249-54

Sox2 transduction enhances cardiovascular repair capacity of blood-derived mesoangioblasts.
Koyanagi M, Iwasaki M, Rupp S, Tedesco FS, Yoon CH, Boeckel JN, Trauth J, Schütz C, Ohtani K, Goetz R, Iekushi K, Bushoven P, Momma S, Mummery C, Passier R, Henschler R, Akintuerk H, Schranz D, Urbich C, Galvez BG, Cossu G, Zeiher AM, Dimmeler S.
Circulation research 2010; 10672010Apr16: 1290-302

Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.
Fadini GP, Boscaro E, de Kreutzenberg S, Agostini C, Seeger F, Dimmeler S, Zeiher A, Tiengo A, Avogaro A.
Diabetes care 2010; 3352010May: 1097-102

Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back.
Chavakis E, Koyanagi M, Dimmeler S.
Circulation 2010; 12122010Jan19: 325-35

Preconditioning by toll-like receptor 2 agonist Pam3CSK4 reduces CXCL1-dependent leukocyte recruitment in murine myocardial ischemia/reperfusion injury.
Mersmann J, Berkels R, Zacharowski P, Tran N, Koch A, Iekushi K, Dimmeler S, Granja TF, Boehm O, Claycomb WC, Zacharowski K.
Critical care medicine 2010; 3832010Mar: 903-9

A regenerative strategy for heart failure in hypoplastic left heart syndrome: intracoronary administration of autologous bone marrow-derived progenitor cells.
Rupp S, Zeiher AM, Dimmeler S, Tonn T, Bauer J, Jux C, Akintuerk H, Schranz D.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2010; 2952010May: 574-7

Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction.
Assmus B, Rolf A, Erbs S, Elsässer A, Haberbosch W, Hambrecht R, Tillmanns H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Tonn T, Dimmeler S, Dill T, Zeiher AM, Schächinger V, .
Circulation. Heart failure 2010; 312010Jan: 89-96